Loading
Sentiment · FY2026 Q1
As of FY2025 Q4, the Tellvest earnings-call sentiment score for Hologic (HOLX) is 6/10.
Hologic closed fiscal 2025 with its strongest quarter, delivering $1,049.5 million in revenue (+6.2%) driven by broad-based strength across Surgical (+10.2%), Breast Health (+4.8%), and organic diagnostics ex-COVID (+5.4%). Non-GAAP operating margin expanded 120 basis points to 31.2% on operating leverage, while non-GAAP EPS grew 11.9% to $1.13. The quarter was overshadowed by the October 21 announcement of a definitive agreement to be acquired by Blackstone and TPG for up to $79 per share, leading the company to suspend guidance and conference calls for FY2026.
Scored from Hologic’s FY2025 Q4 earnings call. The newest quarter is available with Tellvest Pro.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|
| FY2024 Q4 | $988M | +4.5% | $0.76 | +105.4% | 23.3% | 18.1% | $337M |
| FY2025 Q1 | $1.02B | +0.9% | $0.87 | -15.5% | 22.5% | 19.7% | $142M |
| FY2025 Q2 | $1.01B | -1.2% | $-0.08 | -111.1% | -0.7% | -1.7% | $129M |
| FY2025 Q3 | $1.02B | +1.2% | $0.86 | +4.9% | 24.9% | 19.0% | $331M |
| FY2025 Q4 | $1.05B | +6.2% | $0.83 | +9.2% | 22.6% | 17.8% | $325M |
| FY2026 Q1 | $1.05B | +2.5% | $0.79 | -9.2% | 22.6% | 17.1% | $215M |
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free.